Petros Pharmaceuticals Inc Ordinary Shares PTPI
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.03
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 42.37M
- Market Cap
- $118,642.33
- Volume/Avg
- 9,004 / 105,529
Key Statistics
- Price/Earnings (Normalized)
- 0.01
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. The Company is working towards the goal of becoming an innovator in the emerging self-care market, driving expanded access to key nonprescription pharmaceuticals as Over-the-Counter and nonprescription drug products with additional conditions for nonprescription use (ACNU Products) treatment options. Petros is pursuing the development of a proprietary integrated technology solutions platform containing two components: SaaS, designed to assist pharmaceutical companies in operationalizing and commercializing an Rx-to-OTC switch as an element in the development of an ACNU Product, and a potential Software as a Medical Device component, which guides the consumer in navigating appropriate self-selection or deselection.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3
- Website
- https://www.petrospharma.com
Valuation
|
Metric
|
PTPI
|
|---|---|
Price/Earnings (Normalized) | 0.01 |
Price/Book Value | 0.16 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PTPI
|
|---|---|
Quick Ratio | 1.23 |
Current Ratio | 1.25 |
Interest Coverage | — |
Quick Ratio
PTPI
Profitability
|
Metric
|
PTPI
|
|---|---|
Return on Assets (Normalized) | 142.75% |
Return on Equity (Normalized) | 288.95% |
Return on Invested Capital (Normalized) | 281.64% |
Return on Assets
PTPI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|#>@VDP$w | LOCK|%^>QS | $69B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|%M%%&BZ | LOCK|!w!mF | $43B | |||
| Haleon PLC ADR
HLN
| LOCK|>^%PS?R | LOCK|!? | $42B | |||
| Zoetis Inc Class A
ZTS
| LOCK|S&L>^bB | LOCK|?tH | $30B | |||
| Viatris Inc
VTRS
| LOCK|p#f$pN! | LOCK|?KV | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|R! | LOCK|r<? | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|<d?>^?Y | LOCK|W@$ | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^YNQGB! | LOCK|X#& | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|k##c?@Q | LOCK|Bqh## | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|F<?fQ?< | LOCK|pn& | $2B |
United States